Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Blockage of Wnt/beta-catenin signaling by quercetin reduces survival and proliferation of B-1 cells in vitro

Full text
Author(s):
Tavares Novo, Marilia Campos [1] ; Osugui, Lika [1] ; dos Reis, Vanessa Oliveira [1] ; Longo-Maugeri, Ieda Maria [1] ; Mariano, Mario [1] ; Popi, Ana Flavia [1]
Total Authors: 6
Affiliation:
[1] Univ Fed Sao Paulo, UNIFESP, Dept Microbiol Imunol & Parasitol, Disciplina Imunol, BR-04023900 Sao Paulo - Brazil
Total Affiliations: 1
Document type: Journal article
Source: Immunobiology; v. 220, n. 1, p. 60-67, JAN 2015.
Web of Science Citations: 20
Abstract

The Wnt/beta-catenin signaling pathway has been shown to play an important role in controlling the proliferation, survival and differentiation of hematopoietic cells. Several Wnt/beta-catenin signaling components influence hematopoietic cells fate. B-1 cells are self-renewing and spontaneously express both myeloid and lymphoid restricted transcription factors. B-1 lymphocytes play a major role in autoimmunity and are related to CD5(+) B-cell lymphomas and leukemias, such as CLL (chronic lymphocytic leukemia). Herein, we demonstrate that Wnt/beta-catenin pathway is important to B-1 cell survival in vitro. The loss of Wnt signals by quercetin treatment induces a reduction in the proliferation and survival of B-1 cells. Furthermore, the quercetin treatment diminishes IL-6 production by peritoneal cells, a cytokine important to the maintenance of B-1 cells in vitro. Importantly, the IL-6 addition to B-1 cell culture prevents cells from apoptosis, even in the presence of quercetin. These data suggest that a deregulation in beta-catenin signals could result in alterations in B-1 cell proliferation and differentiation. The correlation between Wnt/beta-catenin and IL-6 could point out a mechanism for the expansion of B-1 cells in autoimmune disease and neoplasia. (C) 2014 Elsevier GmbH. All rights reserved. (AU)